No Data
No Data
B.Riley Financial Maintains Cognition Therapeutics(CGTX.US) With Buy Rating, Raises Target Price to $2
Director Makes Bold Move With Major Stock Purchase in Cognition Therapeutics
Insider Purchase: CEO & President of $CGTX Buys 38,851 Shares
Express News | Cognition’s Positive Phase 2 ‘Shimmer’ Study of Zervimesine (Ct1812) in Dementia With Lewy Bodies (Dlb) Will Be Presented in a Podium Presentation at Ilbdc
Cognition's Positive Phase 2 'SHIMMER' Study of Zervimesine (CT1812) in Dementia With Lewy Bodies (DLB) Will Be Presented in a Podium Presentation at ILBDC
Cognition Therapeutics Shows Promising Phase 2 Study Results
Unlock the Full List
kingrotch : thank you for your work


真名有晨 : Thank you very much
Please take care and rest.
iluvpoptarts : sry doc. I'm too busy counting the money your making me too look. muha
IamBadNewz : @Jaguar8 Been waiting (im)patiently for a pop on CGTX given the recent conference and news of insider buying but price hasn’t reacted. Your thoughts?
Jaguar8 OP IamBadNewz : You have to be patient
View more comments...